Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Citi
QuintilesIMS
McKinsey
Accenture
Teva
Baxter
Dow
Federal Trade Commission

Generated: October 22, 2018

DrugPatentWatch Database Preview

Serono Company Profile

« Back to Dashboard

What is the competitive landscape for SERONO, and what generic and branded alternatives to SERONO drugs are available?

SERONO has three approved drugs.



Summary for Serono
US Patents:0
Tradenames:5
Ingredients:3
NDAs:3

Drugs and US Patents for Serono

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Serono METRODIN urofollitropin INJECTABLE;INTRAMUSCULAR 019415-002 Sep 18, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Serono ASELLACRIN 2 somatropin INJECTABLE;INJECTION 017726-002 Jul 21, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Serono FERTINEX urofollitropin INJECTABLE;SUBCUTANEOUS 019415-004 Aug 23, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Serono METRODIN urofollitropin INJECTABLE;INTRAMUSCULAR 019415-003 Sep 18, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Serono

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Serono FERTINEX urofollitropin INJECTABLE;SUBCUTANEOUS 019415-005 Aug 23, 1996 4,589,402 ➤ Try a Free Trial
Serono FERTINEX urofollitropin INJECTABLE;SUBCUTANEOUS 019415-004 Aug 23, 1996 4,845,077 ➤ Try a Free Trial
Serono FERTINEX urofollitropin INJECTABLE;SUBCUTANEOUS 019415-004 Aug 23, 1996 4,589,402 ➤ Try a Free Trial
Serono FERTINEX urofollitropin INJECTABLE;SUBCUTANEOUS 019415-005 Aug 23, 1996 4,845,077 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
McKinsey
Boehringer Ingelheim
Farmers Insurance
McKesson
Colorcon
Daiichi Sankyo
Merck
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.